DR. JULIE KORENBERG, M.D.
Medical Practice in Los Angeles, CA
License number
California A40959
Category
Medical Practice
Type
Specialist
Address
Address
8700 Beverly Blvd., Los Angeles, CA 90048
Phone
(310) 967-1884
(310) 967-1744 (Fax)
(310) 967-1744 (Fax)
Personal information
See more information about JULIE KORENBERG at radaris.comName
Address
Phone
8125 Skyline Dr, Los Angeles, CA 90046
8125 Skyline Dr, Los Angeles, CA 90046
Professional information
See more information about JULIE KORENBERG at trustoria.com
Dr. Julie R Korenberg, Salt Lake City UT - MD (Doctor of Medicine)
Dr. Julie R Korenberg, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics, Clinical Molecular Genetics
Address:
383 S Colorow Dr SUITE 362, Salt Lake City 84108
(801) 587-0777 (Phone)
8700 Beverly Blvd SUITE D-2069, Los Angeles 90048
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
(801) 587-0777 (Phone)
8700 Beverly Blvd SUITE D-2069, Los Angeles 90048
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
Certifications:
Clinical Genetics, 1987, Clinical Molecular Genetics, 1993, Pediatrics, 1984
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
383 S Colorow Dr SUITE 362, Salt Lake City 84108
8700 Beverly Blvd SUITE D-2069, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
8700 Beverly Blvd SUITE D-2069, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
University of Miami / School of Medicine
Graduated: 1979
Chldns Hosp Mc-Harvard Med Sch
Ina Sue Perlmutter Cf Rsch Ctr-Harvard
U San Francisco
University of Miami / School of Medicine
Graduated: 1979
Chldns Hosp Mc-Harvard Med Sch
Ina Sue Perlmutter Cf Rsch Ctr-Harvard
U San Francisco
Congenital Heart Disease Proteins And Products Related Thereto
Congenital Heart Disease Proteins And Products Related Thereto
US Patent:
6040429, Mar 21, 2000
Filed:
Aug 30, 1999
Appl. No.:
9/385947
Inventors:
Julie R. Korenberg - Los Angeles CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C07K 1400, C12N 1500, C12P 2100, C07H 2104
US Classification:
530350
Abstract:
In accordance with the present invention, there are provided novel Congenital Heart Disease (CHD) proteins. Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention CHD proteins can be employed in a variety of ways, for example, for the production of anti-CHD antibodies thereto, in therapeutic compositions and methods employing such proteins and/or antibodies.
Chromosome 21 Gene Marker, Compositions And Methods Using Same
Chromosome 21 Gene Marker, Compositions And Methods Using Same
US Patent:
6166180, Dec 26, 2000
Filed:
Mar 26, 1998
Appl. No.:
9/048887
Inventors:
Julie R. Korenberg - Los Angeles CA
Kazuhiro Yamakawa - Los Angeles CA
Kazuhiro Yamakawa - Los Angeles CA
Assignee:
Cedar-Sinai Medical Center - Los Angeles CA
International Classification:
C07K 1447
US Classification:
530350
Abstract:
The present invention provides isolated nucleic acids encoding human EHOC-1 protein and isolated receptor proteins encoded thereby. Further provided are vectors containing invention nucleic acids, probes that hybridize thereto, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing, antibodies that specifically bind to invention polypeptides and compositions containing, as well as transgenic non-human mammals that express the invention protein.
Novel Chromosome 21 Gene Marker, Compositions And Methods Using Same
Novel Chromosome 21 Gene Marker, Compositions And Methods Using Same
US Patent:
2004018, Sep 16, 2004
Filed:
Dec 26, 2000
Appl. No.:
09/749273
Inventors:
Julie Korenberg - Los Angeles CA, US
Kazuhiro Yamakawa - Los Angeles CA, US
Kazuhiro Yamakawa - Los Angeles CA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/00, C12P021/02, C12N005/06
US Classification:
435/006000, 435/183000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
The present invention provides isolated nucleic acids encoding human EHOC-1 protein and isolated receptor proteins encoded thereby. Further provided are vectors containing invention nucleic acids, probes that hybridize thereto, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing, antibodies that specifically bind to invention polypeptides and compositions containing, as well as transgenic non-human mammals that express the invention protein.
Nucleic Acid Encoding Congenital Heart Disease Protein And Products Related Thereto
Nucleic Acid Encoding Congenital Heart Disease Protein And Products Related Thereto
US Patent:
5945305, Aug 31, 1999
Filed:
Sep 11, 1997
Appl. No.:
8/927307
Inventors:
Julie R. Korenberg - Los Angeles CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C12N 1500, C12N 1563, C12N 1585, C07H 2104
US Classification:
435 691
Abstract:
In accordance with the present invention, there are provided novel Congenital Heart Disease (CHD) proteins. Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention CHD proteins can be employed in a variety of ways, for example, for the production of anti-CHD antibodies thereto, in therapeutic compositions and methods employing such proteins and/or antibodies.
Chromosome 21 Gene Marker, Compositions And Methods Using Same
Chromosome 21 Gene Marker, Compositions And Methods Using Same
US Patent:
5773268, Jun 30, 1998
Filed:
Nov 9, 1994
Appl. No.:
8/337690
Inventors:
Julie R. Korenberg - Los Angeles CA
Kazuhiro Yamakawa - Los Angeles CA
Kazuhiro Yamakawa - Los Angeles CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C12N 1512, C12N 1585, C12N 510
US Classification:
4351723
Abstract:
The present invention provides isolated nucleic acids encoding human EHOC-1 protein and isolated receptor proteins encoded thereby. Further provided are vectors containing invention nucleic acids, probes that hybridize thereto, host cells transformed therewith, antisense oligonucleotides thereto and compositions containing, antibodies that specifically bind to invention polypeptides and compositions containing, as well as transgenic non-human mammals that express the invention protein.
Isolated Sh3 Genes Associates With Myeloproliferative Disorders And Leukemia And Uses Thereof
Isolated Sh3 Genes Associates With Myeloproliferative Disorders And Leukemia And Uses Thereof
US Patent:
7070954, Jul 4, 2006
Filed:
Apr 16, 1999
Appl. No.:
09/720934
Inventors:
Julie R. Korenberg - Los Angeles CA, US
Xiao-Ning Chen - Arcadia CA, US
Xiao-Ning Chen - Arcadia CA, US
International Classification:
C12N 15/00
US Classification:
435 691, 536 231, 4353201, 435325, 4352523, 4352542
Abstract:
The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human gene (SH3D1A), some polymorphic alleles of which cause susceptibility to cancers hematopoietic disorders and in particular platelet disorders, Down Syndrome, megakaryocytic disorders and leukemia. More specifically, the invention relates to isolated nucleic acid of the human SH3D1A gene, products, and their use in diagnosis and treatments. The invention further relates to the screening of drugs for cancer therapy. Finally, the invention relates to the screening of the SH3D1A gene for mutations, which are useful for diagnosing the predisposition to hematopoietic disorders.
Nucleic Acid Encoding Ds-Cam Proteins And Products Related Thereto
Nucleic Acid Encoding Ds-Cam Proteins And Products Related Thereto
US Patent:
2006005, Mar 9, 2006
Filed:
May 20, 2005
Appl. No.:
11/134587
Inventors:
Julie Korenberg - Los Angeles CA, US
International Classification:
C12Q 1/68, C07H 21/04, C12P 21/06, C07K 14/705
US Classification:
435006000, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:
In accordance with the present invention, there are provided novel Down Syndrome-Cell Adhesion Molecule (DS-CAM) proteins. Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention DS-CAM proteins can be employed in a variety of ways, for example, for the production of anti-DS-CAM antibodies thereto, in therapeutic compositions and methods employing such proteins and/or antibodies. DS-CAM proteins are also useful in bioassays to identify agonists and antagonists thereto.
Nucleic Acid Encoding Ds-Cam Proteins And Products Related Thereto
Nucleic Acid Encoding Ds-Cam Proteins And Products Related Thereto
US Patent:
6960656, Nov 1, 2005
Filed:
Oct 23, 1997
Appl. No.:
08/956991
Inventors:
Julie R. Korenberg - Los Angeles CA, US
Assignee:
Cedars Sinai Medical Center - Los Angeles CA
International Classification:
C07H021/04
US Classification:
536 231, 536 241, 536 2433, 4353201, 4352523
Abstract:
In accordance with the present invention, there are provided Down Syndrome-Cell Adhesion Molecule (DS-CAM) proteins. Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention DS-CAM proteins can be employed in a variety of ways, for example, for the production of anti-DS-CAM antibodies thereto, in therapeutic compositions and methods employing such proteins and/or antibodies. DS-CAM proteins are also useful in bioassays to identify agonists and antagonists thereto.